GlassScriptPhysician profile
Jonathan Michael Morris
NPI 1487912515
$6,225.31
in general payments reported to CMS, 2019-2025
11 companies · $2,961 in 2025
The $2,961 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,051 · 2022: $138 · 2023: $185 · 2024: $891 · 2025: $2,961.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,824 · Consulting Fee: $1,150 · Travel and Lodging: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,823.57 |
| Consulting Fee | $1,150.00 |
| Travel and Lodging | $1,062.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $2,449.07 | 2024-2025 | Genflex2 Total Knee System, Senza, Actify 3d |
| Izi Medical Products, LLC | $2,000.00 | 2021 | |
| Onkos Surgical, INC. | $640.51 | 2023-2025 | Eleos Limb Salvage System |
| Cerapedics INC. | $274.80 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Aadi Bioscience, INC. | $243.90 | 2024-2025 | Fyarro |
| Smith+Nephew, INC. | $159.54 | 2022-2023 | Real Intelligence |
| Medtronic, INC. | $158.54 | 2024 | Osteocool Rf Ablation System |
| Stryker Corporation | $108.87 | 2021-2025 | Mako |
| Shalby Advanced Technologies, INC. | $71.69 | 2024 | Cks - Vitalite, Consensus Knee System |
| Integrum INC. | $65.23 | 2023 | Opra Implant System |
| Illuminoss Medical, INC. | $53.16 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.